MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » Digirad acquires cardiac monitoring services provider Telerhythmics for $3.6M

Digirad acquires cardiac monitoring services provider Telerhythmics for $3.6M

By

Digirad acquires cardiac monitoring services provider Telerhythmics for $3.6M

Imaging technologies company Digirad Corp.(NSDQ:DRAD) acquired out-sourced cardiac monitoring services provider Telerhythmics in a deal worth up to $4.1 million.

The deal provides for about $3.5 million in cash, about $131,000 in debt and another possible $500,000 in earn-outs over the course of 3 years. The Telerhythmics team is planning to stay in Memphis, Tenn., rather than moving to join its new parent company in Suwanee, Ga., were Digirad moved its headquarters earlier this year.

"The addition of Telerhythmics fits squarely in our business model and our mission to provide medical services and technology on an as needed, where needed and when needed basis," Digirad president & CEO Matthew Molchan said in prepared remarks. "Its target market is virtually the same as our target market with DIS, and acquiring Telerhythmics allows us to drive additional services via our existing channels and expand and diversify our business operations, allowing us more opportunities to grow and broaden our geographic reach."

The announcement came a couple of weeks after Digirad announced its 4th-quarter earnings results, featuring a swing to the black for the full year. The company also announced recent efforts to cut costs my outsourcing some of its manufacturing.

For the 3 months ended December 31, Digirad posted profits of $787,000, or 4¢ per diluted share, on sales of $12.5 million. That compared with losses of $1.9 million, or 10¢ per share, on sales of $13 million during the same period the previous year.

For the full year, Digirad posted profits of $264,000, or 1¢ per share, on sales of $49.4 million. That compared with losses of $4.9 million, or 26¢ per share, on sales of $50.5 million in 2012. Adjusted for special items, 2013 per-share earnings amounted to 2¢, according to the report.

The company in January announced efforts to save some cash and streamline operations by shifting its headquarters to Georgia and moving its camera manufacturing, service and support operations to an outsourced provider in the San Diego area.

DRAD shares closed last night at $3.52, up 2.9% on the day. The stock has lost 4.9% since the start of the year.

In case you missed it

RSS From Medical Design & Outsourcing

  • FDA and VA Ventures Innovation Institute partner on new medical device testing tools
    The Department of Veterans Affairs’ VA Ventures Innovation Institute in Seattle will host up to a dozen FDA staffers in a new collaboration to develop and share new tools for medical device testing safety and efficacy. The agencies intend to provide developers of devices and new technology with off-the-shelf tools that can help streamline regulatory… […]
  • How Boston Scientific is managing labor shortages with cobots and Spanish
    Boston Scientific (NYSE: BSX) executives said two labor-shortage strategies are paying off in a big way for the medical device maker, which has around 41,000 employees across the globe. Collaborative robotics and Spanish-speaking shifts are helping Boston Scientific deal with labor shortages in the U.S. and elsewhere. That’s according to Global Operations EVP Brad Sorenson… […]
  • 6 power management considerations for developing and scaling smaller, smarter micromedical devices
    Supercharge every phase of micromedical device product development with these questions. Mitch Johnson, Intricon Some of the biggest considerations for designing, manufacturing and scaling today’s smaller, smarter medical innovations center on providing power to microelectronic systems. From mechanical functionality to data operations and wireless communications, effective power management drives continued device innovation. Addressing five fundamental… […]
  • Evonik, Coopmed agree on wound dressing distro deal
    Evonik announced today that it signed an agreement for medical technology company Coopmed to distribute the epicite wound dressing. Jena, Germany-based Evonik said Coopmed will distribute the epicite dressing made from biosynthetic cellulose exclusively to the German market for chronic wound care. Epicite represents part of the portfolio from JeNaCell, which Evonik acquired in 2021.… […]
  • Spartech hires Bosch VP Dan Gallo as chief operating officer
    Spartech today said it hired Dan Gallo as chief operating officer of the engineered thermoplastics and custom packaging manufacturer. Gallo started this month, according to his LinkedIn page. His career leading operations, supply chain and logistics functions spans more than three decades. He was most recently an operations VP at Robert Bosch. Before his time… […]
  • 3M launches Verify platform to spot counterfeit products
    3M (NYSE:MMM) announced today that it established a new 3M Verify platform to report potential counterfeit 3M products. The effort builds upon its anti-counterfeit efforts during the height of the COVID-19 pandemic. At the time, a number of sellers claimed to offer 3M respirators. Instead, many offered fake, defective and damaged N95 masks at inflated… […]
  • FDA will review fewer COVID-19 test EUA submissions
    The FDA is pushing COVID-19 test developers away from emergency use authorization (EUA) submissions in favor of more traditional pathways, the agency said today. The FDA said it intends to review “only a small subset” of new EUA submissions, encouraging test makers to seek regulatory approval through de novo classification or 510(k) clearance pre-market review… […]
  • Integra plans to shrink the C-suite after executive’s exit
    Integra Lifesciences (Nasdaq: IART) will eliminate the position of chief operating officer next week — though the office is already empty. Former COO Glenn Coleman’s last day at Integra was Friday, according to a separation agreement filed with the Securities and Exchange Commission that same day. Coleman was scheduled to start as the new EVP and… […]
  • Steris plans to build a new medical device testing facility
    Steris (NYSE: STE) plans to build a new packaging and microbiological testing facility for medical devices in Leipzig, Germany. The facility will offer packaging testing services such as accelerated and real-time aging, transportation and integrity testing. The new location will also offer microbiological testing in collaboration with the medical device manufacturer and sterilizer’s laboratory in… […]
  • 10 medical device startups you need to know
    Some of the most interesting medical device startups of 2022 are advancing a wide range of innovative medtech: robotics, catheter-delivered brain-computer interfaces and more. The editors here at Medical Design & Outsourcing and MassDevice are writing about medical device startups all the time. But there are some device companies starting out that have technologies that… […]
  • Steris stock downgraded as analysts expect lawyers to seek more ethylene oxide lawsuits
    Steris (NYSE: STE) stock was downgraded today by Needham from buy to hold following the $363 million jury verdict against its primary competitor, Sterigenics, over ethylene oxide (EtO) emissions. Needham analysts said they expect attorneys to target communities near EtO facilities with ads to find people willing to file more lawsuits against sterilization plant operators… […]

Leave a Reply